SARS-CoV-2 Nucleocapsid Antikörper (C-Term)
Kurzübersicht für SARS-CoV-2 Nucleocapsid Antikörper (C-Term) (ABIN7272991)
Target
Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- anti-Nucleocapsid (SARS-CoV-2)
-
Sequenz
- MQTQGNFGDQ ELIRQGTDYK HWPQIAQFAP SASAFFGMSR IGMEVTPSGT WLTYTGAIKL DDKDPNFKDQ VILLNKHIDA YKTFPPTEPK KDKKKKADET QALPQRQKKQ QTVTLLPAAD LDDFSKQLQQ SMSSADSTQA
-
Spezifität
- In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Kreuzreaktivität (Details)
- Reacts with SARS-CoV-2 protein
-
Aufreinigung
- Epitope affinity purified
-
Immunogen
- Affinity purified recombinant fusion protein using the C-terminal of Nucleocapsid (residues 280 to stop) and produced in E. coli
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- The antibody solution should be gently mixed before use.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
-
Andere Bezeichnung
- Nucleocapsid (SARS-CoV-2)
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
The nucleocapsid protein is one of the core components of the SARS coronavirus (CoV). This protein forms a closed capsule, inside which the genomic RNA is securely stored, and it is also involved in packaging the RNA into virus particles.
SARS Coronavirus-2, SARS-CoV-2 NP, SARS-CoV-2 N protein antibody.
Target
-